Clark; Kelly Reed

Patent Applications and Registrations

Patent applications and USPTO patent grants for Clark; Kelly Reed.The latest application filed is for "recombinant virus products and methods for inhibiting expression of dystrophia myotonica protein kinase and/or interfering with a trinucleotide repeat expansion in the 3' untranslated region of the dmpk gene".

Company Profile

3.6.17

Clark; Kelly Reed - Columbus OH
Clark; Kelly Reed - Westerville OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides Grant 11,446,396 - Mendell , et al. September 20, 2	2022-09-20
Recombinant Virus Products And Methods For Inhibiting Expression Of Dystrophia Myotonica Protein Kinase And/or Interfering With A Trinucleotide Repeat Expansion In The 3' Untranslated Region Of The Dmpk Gene App 20220033823 - Wein; Nicolas Sebastien ; et al.	2022-02-03
Methods And Compositions For Treating Glycogen Storage Diseases App 20220017922 - Tipper; Christopher ; et al.	2022-01-20
Gene Therapy For Treating Propionic Acidemia App 20210283272 - Fuller; Matthew Scott ; et al.	2021-09-16
Methods For Enhancing Yield Of Recombinant Adeno-associated Virus App 20200048641 - Jing; Ying ; et al.	2020-02-13
Use Of Glucocorticoid Analogs To Enhance Recombinant Adeno-associated Virus Yield App 20190290710 - Jing; Ying ; et al.	2019-09-26
Recombinant Adeno-associated Virus Delivery Of Alpha-sarcoglycan Polynucleotides App 20190000998 - Mendell; Jerry R. ; et al.	2019-01-03
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides Grant 10,105,453 - Mendell , et al. October 23, 2	2018-10-23
Recombinant Adeno-associated Virus Delivery Of Alpha-sarcoglycan Polynucleotides App 20170209598 - Mendell; Jerry R. ; et al.	2017-07-27
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides Grant 9,434,928 - Mendell , et al. September 6, 2	2016-09-06
Expression Of Virus Entry Inhibitors And Recombinant Aav Therefor App 20150044170 - Johnson, JR.; Philip R. ; et al.	2015-02-12
Recombinant Adeno-associated Virus Delivery Of Alpha-sarcoglycan Polynucleotides App 20140323956 - Mendell; Jerry R. ; et al.	2014-10-30
Recombinant adeno-associated virus production Grant 8,409,842 - Clark , et al. April 2, 2	2013-04-02
Expression Of Virus Entry Inhibitors And Recombinant Aav Therefor App 20120171160 - Johnson, JR.; Philip R. ; et al.	2012-07-05
Antibody Gene Transfer And Recombinant Aav Therefor App 20120027798 - Clark; Kelly Reed ; et al.	2012-02-02
Recombinant Adeno-Associated Virus Production App 20090291503 - Clark; Kelly Reed ; et al.	2009-11-26
Expression of virus entry inhibitors and recombinant AAV therefor App 20090169513 - Johnson, JR.; Philip R. ; et al.	2009-07-02
Recombinant adeno-associated virus production Grant 7,510,872 - Clark , et al. March 31, 2	2009-03-31
Antibody Gene Transfer and Recombinant AAV Therefor App 20090035327 - Clark; Kelly Reed ; et al.	2009-02-05
Expression of virus entry inhibitors and recombinant AAV thereof App 20070041943 - Johnson; Philip R. JR. ; et al.	2007-02-22
Recombinant adeno-associated virus production App 20040224411 - Clark, Kelly Reed ; et al.	2004-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.